AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

KANABO GROUP PLC

Report Publication Announcement Nov 19, 2024

4978_rns_2024-11-19_20e4eaec-99fa-4053-a7b3-3d070ff8ff58.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8036M

Kanabo Group PLC

19 November 2024

19 November 2024

Kanabo Group Plc

The GP Service Wins Award

Kanabo Group Plc ("Kanabo" or "the Company"), a leader in medical cannabis and telemedicine innovation, is pleased to announce that its subsidiary, The GP Service, has been named the winner of the Lloyds British Business Excellence Award for Tech Business of the Year. This prestigious recognition highlights The GP Service's leadership in healthcare technology, competing with some of the UK's most forward-thinking companies.

Strategic Growth and Innovation

Since its acquisition by Kanabo in February 2022, The GP Service has strengthened its position in the healthcare market through its robust technology platform and a network of over 6,000 pharmacies across the UK. This infrastructure facilitates secure and seamless electronic prescription delivery, demonstrating its scalability as a patient-focused solution bridging the gap between technology and accessible healthcare.

To align with its strategy of profitability and operational efficiency, The GP Service has restructured its clinical operations by outsourcing services to trusted third-party providers. This move reduces regulatory complexity while sharpening its focus on technology and scalability. This strategic shift enables The GP Service to concentrate on developing innovative solutions that enhance patient access and clinician support.

AI-Driven Expansion

The GP Service continues to refine its proprietary AI-powered Voice and Chat Bot technology, incorporating patient feedback and further testing to optimize its capabilities. Initial beta tests have shown promise. By automating patient consultations, gathering medical data, and supporting clinicians with prescription recommendations, this solution is poised to reduce administrative burdens, improve patient care, and enhance scalability.

Suleman Sacranie, Co-Founder of The GP Service, commented:

"This award is a powerful validation of our mission to make healthcare more accessible, efficient, and patient-focused. Competing against the UK's top technology companies, we're honored to be recognised for our innovation and impact. We look forward to continuing to redefine telemedicine and deliver value to patients and partners."

Ian Mattioli, Chairman of Kanabo Group Plc, added:

"The GP Service's recognition as Tech Company of the Year demonstrates its potential to set new benchmarks in healthcare innovation. While Kanabo supports its growth, The GP Service continues to chart its course as a scalable, technology-driven business delivering value to patients and partners."

Enquiries:

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Ian Mattioli, Non-Executive Chair of the Board
Peterhouse Capital Ltd (Financial Adviser) +44 (0)20 7469 0930

About Kanabo Group Plc

Kanabo Group Plc is a pioneering developer of medical cannabis and telemedicine solutions. Through strategic acquisitions and innovative technologies, the company is shaping the future of global healthcare accessibility and outcomes.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUKVKRSSUAARA

Talk to a Data Expert

Have a question? We'll get back to you promptly.